AI Analysis

Log in to generate an AI summary for this stock.

Log in to generate a MOAT report for this stock.

Log in to generate an earnings report for this stock.

Log in to generate an operating leverage report for this stock.

Log in to generate a management report for this stock.

Log in to generate a valuation report for this stock.

PharmGen Science, Inc.

₩2970 -$1430.00 (-32.50%)
KSC · 15 Sep 2026 06:30 UTC
Previous Close
₩3030
Day Range
₩2945₩3045
Year Range
₩2590₩4600
Market Cap
65.08B
AVG Volume
67.2K
Trailing/Forward PE
-0.48/-
PEG ratio
0
Dividend Yield
-
Next Earnings Date
-
Primary Exchange
Korea ExchangeKR
Revenue (KRW)
050B100B150B200B2016201720182019202020212022202320242025
004720.KS Revenue (KRW) by year
PeriodRevenue (KRW)
2025173.07B
2024171.29B
2023166.78B
2022150.93B
2021109.87B
202096.61B
201995.14B
201889.1B
201779.89B
201671.55B
Net Income (KRW)
-150B-100B-50B050B100B2016201720182019202020212022202320242025
004720.KS Net Income (KRW) by year
PeriodNet Income (KRW)
2025-116.66B
20242.79B
20235.73B
202270.06B
202132.47B
20209.22B
2019301.98M
20184.47B
20174.32B
20163.45B
Operating Income (KRW)
-25B025B50B75B100B2016201720182019202020212022202320242025
004720.KS Operating Income (KRW) by year
PeriodOperating Income (KRW)
20255.99B
202410.64B
20239.13B
202293.47B
2021-5.04B
2020-669.9M
20191.19B
20184.99B
20176.01B
20164.84B
EBITDA (KRW)
020B40B60B2016201720182019202020212022202320242025
004720.KS EBITDA (KRW) by year
PeriodEBITDA (KRW)
202510.06B
20249.81B
202313.44B
202210.78B
202146.81B
202012.01B
20194.03B
20186.17B
20176.84B
20165.29B
Cash Flows (KRW)
-30B-20B-10B010B2016201720182019202020212022202320242025
004720.KS Cash Flows (KRW) by year
PeriodCash Flows (KRW)
20253.5B
2024-80.16M
20232.15B
2022-13.24B
2021-26.23B
2020-2.79B
2019-4.26B
20183.24B
2017-179.23M
20164.32B
EPS (KRW)
-7500-5000-25000250050002016201720182019202020212022202320242025
004720.KS EPS (KRW) by year
PeriodEPS (KRW)
2025-5327.89
2024151.66
2023276.99
20223365.04
20211764.81
2020676.09
201926.07
2018387.01
2017388.49
2016367.57
Expenses (KRW)
025B50B75B100BR&DSG&ACapex2016201720182019202020212022202320242025
004720.KS Expenses (KRW) by year
PeriodExpenses (KRW)
202592.45B
202492.43B
202374.74B
202262.67B
202175.25B
202037.74B
201935.25B
201822.9B
201719.9B
201621.1B
Cash & Debt (KRW)
020B40B60BCashLong Term DebtShort Term Debt2016201720182019202020212022202320242025
004720.KS Cash & Debt (KRW) by year
PeriodCash & Debt (KRW)
202522.41B
202438.45B
202337.44B
202219.89B
202134.19B
202030.45B
201915.93B
201845.94B
201722.01B
201623.4B
Debt ratios
-1.5-1-0.500.520182019202020212022202320242025
004720.KS Debt ratios by year
PeriodDebt ratios
2025-0.37
20240.01
20230.01
20220.27
20210.2
2020-0.31
20190.17
2018-1.14
Margins
0%20%40%60%80%2016201720182019202020212022202320242025
004720.KS Margins by year
PeriodMargins
202564.15%
202462.73%
202358.43%
202253.87%
202155.34%
202055.48%
201952.98%
201851.85%
201751.63%
201655.88%
Return on Capital
-100%-50%0%50%2016201720182019202020212022202320242025
004720.KS Return on Capital by year
PeriodReturn on Capital
2025-79.74%
20241.12%
20232.51%
202233.83%
202125.58%
202011.04%
20190.54%
20187.86%
20178.46%
20169.48%
Shares Outstanding
010M20M30M2016201720182019202020212022202320242025
004720.KS Shares Outstanding by year
PeriodShares Outstanding
202521.95M
202418.16M
202317.96M
202215.79M
202114.72M
202013.45M
201911.53M
201811.57M
201711.21M
20169.39M
Book Value Per Share (KRW)
0500010000150002016201720182019202020212022202320242025
004720.KS Book Value Per Share (KRW) by year
PeriodBook Value Per Share (KRW)
20256663.81
202413735.79
202312706.25
202213117.73
20218624.8
20206214.63
20194878.91
20184914.51
20174555.1
20163879.16
Total Assets (KRW)
0100B200B300B400B2016201720182019202020212022202320242025
004720.KS Total Assets (KRW) by year
PeriodTotal Assets (KRW)
2025195.41B
2024363.45B
2023335.92B
2022317.39B
2021220.32B
2020135.54B
2019100.03B
201898.19B
201768.48B
201664.3B
PE Ratio
0200400600800med 24.88Apr 24Jul 24Nov 24May 25Aug 25Dec 25Mar 26
004720.KS PE Ratio by year
PeriodPE Ratio
Mar 2615.12
Mar 2614.86
Mar 2615.12
Mar 2614.7
Feb 2615.56
Feb 2616.19
Feb 2616.19
Feb 2616.63
Jan 2616.68
Jan 2616.72
Jan 2616.03
Jan 2616.76
Jan 2617.44
Dec 2525.81
Dec 2526.18
Dec 2526.03
Dec 2525.78
Nov 2524.97
Nov 2524.14
Nov 2525.44
Nov 2524.79
Oct 2524.97
Oct 2524.97
Oct 2525.1
Oct 2526
Oct 2527.17
Sep 25675.71
Sep 25706.5
Sep 25692.64
Sep 25676.48
Aug 25678.79
Aug 25683.41
Aug 25703.42
Aug 25704.96
Aug 25686.49
Jul 25657.24
Jul 25684.18
Jul 25665.71
Jul 25664.94
Jun 2527.69
Jun 2528.4
Jun 2528.24
Jun 2528.69
May 2527.82
May 2527.43
May 2525.6
May 2525.96
May 2526.38
Apr 2526.32
Apr 2526.38
Apr 2525.99
Apr 2525.57
Dec 24131.95
Dec 24137.33
Dec 24141.24
Dec 24145.64
Nov 24150.69
Nov 24152.97
Nov 24151.5
Nov 24159.97
Nov 24153.3
Oct 24150.85
Oct 24159.97
Oct 24156.07
Oct 24160.14
Sep 2414.63
Sep 2414.5
Sep 2414.02
Sep 2413.6
Aug 2414.98
Aug 2415.77
Aug 2417.35
Aug 2416.27
Aug 2415.48
Jul 2415.68
Jul 2415.51
Jul 2415.42
Jul 2415.33
Jun 2416.43
Jun 2416.4
Jun 2416.75
Jun 2416.71
May 2416.59
May 2417.22
May 2417.44
May 2416.97
May 2416.93
Apr 2416.43
Apr 2416.06
Apr 2417.03
Apr 2417.25
Mar 2418.86
Mar 2419.53
Mar 2418.86
Mar 2419.03
Feb 2419.23
Feb 2419.83
Feb 2419.7
Feb 2419.43
Feb 2419.4
Free Cash Flow Yield
-10%-5%0%5%10%15%med -0.1%Dec 24Apr 25Jul 25Nov 25Feb 26Jun 26Sep 26
004720.KS Free Cash Flow Yield by year
PeriodFree Cash Flow Yield
Sep 2612.36%
Sep 2612.38%
Sep 2612.2%
Aug 2611.5%
Aug 2611.98%
Aug 2611.33%
Aug 2611.45%
Jul 2611.52%
Jul 2610.89%
Jul 2611.01%
Jul 2612.28%
Jul 2611.74%
Jun 265.55%
Jun 265.47%
Jun 264.99%
Jun 265.16%
May 264.84%
May 264.33%
May 264.28%
May 263.97%
Apr 263.8%
Apr 264.12%
Apr 264%
Apr 264.24%
Apr 264.36%
Mar 26-2.49%
Mar 26-2.54%
Mar 26-2.49%
Mar 26-2.56%
Feb 26-2.42%
Feb 26-2.33%
Feb 26-2.33%
Feb 26-2.27%
Jan 26-2.26%
Jan 26-2.25%
Jan 26-2.35%
Jan 26-2.25%
Jan 26-2.16%
Dec 25-4.99%
Dec 25-4.91%
Dec 25-4.94%
Dec 25-4.99%
Nov 25-5.15%
Nov 25-5.33%
Nov 25-5.06%
Nov 25-5.19%
Oct 25-5.15%
Oct 25-5.15%
Oct 25-5.13%
Oct 25-4.95%
Oct 25-4.74%
Sep 25-3.94%
Sep 25-3.77%
Sep 25-3.84%
Sep 25-3.93%
Aug 25-3.92%
Aug 25-3.89%
Aug 25-3.78%
Aug 25-3.77%
Aug 25-3.88%
Jul 25-4.05%
Jul 25-3.89%
Jul 25-4%
Jul 25-4%
Jun 25-0.1%
Jun 25-0.1%
Jun 25-0.1%
Jun 25-0.1%
May 25-0.1%
May 25-0.1%
May 25-0.11%
May 25-0.11%
May 25-0.11%
Apr 25-0.11%
Apr 25-0.11%
Apr 25-0.11%
Apr 25-0.11%
Mar 251.26%
Mar 251.23%
Mar 251.21%
Mar 251.19%
Feb 251.15%
Feb 251.14%
Feb 251.17%
Feb 251.15%
Jan 251.17%
Jan 251.14%
Jan 251.11%
Jan 251.11%
Jan 251.16%
Dec 241.27%
Dec 241.22%
Dec 241.19%
Dec 241.15%
Nov 241.11%
Nov 241.1%
Nov 241.11%
Nov 241.05%
Nov 241.09%
Oct 241.11%
Price to Sales
0.350.40.450.50.55med 0.44Dec 24Apr 25Jul 25Nov 25Feb 26Jun 26Sep 26
004720.KS Price to Sales by year
PeriodPrice to Sales
Sep 260.38
Sep 260.38
Sep 260.39
Aug 260.41
Aug 260.39
Aug 260.42
Aug 260.41
Jul 260.41
Jul 260.43
Jul 260.43
Jul 260.39
Jul 260.4
Jun 260.36
Jun 260.37
Jun 260.41
Jun 260.39
May 260.42
May 260.47
May 260.47
May 260.51
Apr 260.53
Apr 260.49
Apr 260.5
Apr 260.48
Apr 260.46
Mar 260.4
Mar 260.39
Mar 260.4
Mar 260.38
Feb 260.41
Feb 260.42
Feb 260.42
Feb 260.43
Jan 260.44
Jan 260.44
Jan 260.42
Jan 260.44
Jan 260.46
Dec 250.43
Dec 250.44
Dec 250.44
Dec 250.43
Nov 250.42
Nov 250.4
Nov 250.43
Nov 250.42
Oct 250.42
Oct 250.42
Oct 250.42
Oct 250.44
Oct 250.46
Sep 250.46
Sep 250.48
Sep 250.48
Sep 250.46
Aug 250.47
Aug 250.47
Aug 250.48
Aug 250.48
Aug 250.47
Jul 250.45
Jul 250.47
Jul 250.46
Jul 250.46
Jun 250.45
Jun 250.46
Jun 250.46
Jun 250.47
May 250.45
May 250.45
May 250.42
May 250.42
May 250.43
Apr 250.43
Apr 250.43
Apr 250.42
Apr 250.42
Mar 250.42
Mar 250.43
Mar 250.44
Mar 250.44
Feb 250.46
Feb 250.46
Feb 250.45
Feb 250.45
Jan 250.45
Jan 250.46
Jan 250.47
Jan 250.47
Jan 250.45
Dec 240.42
Dec 240.44
Dec 240.45
Dec 240.47
Nov 240.48
Nov 240.49
Nov 240.49
Nov 240.51
Nov 240.49
Oct 240.48
EV/EBITDA
4681012med 7.45Dec 24Apr 25Jul 25Nov 25Feb 26Jun 26Sep 26
004720.KS EV/EBITDA by year
PeriodEV/EBITDA
Sep 265.63
Sep 265.62
Sep 265.72
Aug 266.15
Aug 265.85
Aug 266.26
Aug 266.18
Jul 266.13
Jul 266.57
Jul 266.48
Jul 265.67
Jul 266
Jun 264.63
Jun 264.72
Jun 265.34
Jun 265.11
May 265.55
May 266.4
May 266.5
May 267.12
Apr 267.53
Apr 266.81
Apr 267.06
Apr 266.57
Apr 266.35
Mar 2610.1
Mar 269.93
Mar 2610.1
Mar 269.83
Feb 2610.37
Feb 2610.78
Feb 2610.78
Feb 2611.05
Jan 2611.09
Jan 2611.12
Jan 2610.68
Jan 2611.14
Jan 2611.57
Dec 259.16
Dec 259.28
Dec 259.23
Dec 259.15
Nov 258.89
Nov 258.61
Nov 259.04
Nov 258.83
Oct 258.89
Oct 258.89
Oct 258.93
Oct 259.22
Oct 259.61
Sep 259.61
Sep 2510.02
Sep 259.84
Sep 259.62
Aug 259.65
Aug 259.71
Aug 259.98
Aug 2510
Aug 259.76
Jul 259.37
Jul 259.72
Jul 259.48
Jul 259.47
Jun 257.93
Jun 258.14
Jun 258.09
Jun 258.22
May 257.97
May 257.86
May 257.34
May 257.44
May 257.56
Apr 257.54
Apr 257.56
Apr 257.45
Apr 257.33
Mar 254.39
Mar 254.48
Mar 254.57
Mar 254.64
Feb 254.78
Feb 254.83
Feb 254.71
Feb 254.76
Jan 254.71
Jan 254.8
Jan 254.93
Jan 254.93
Jan 254.75
Dec 245.03
Dec 245.23
Dec 245.37
Dec 245.53
Nov 245.72
Nov 245.8
Nov 245.75
Nov 246.06
Nov 245.81
Oct 245.72
Price/Operating Cashflow
01000200030004000med 22.39Jun 24Oct 24Jan 25May 25Feb 26Jun 26Sep 26
004720.KS Price/Operating Cashflow by year
PeriodPrice/Operating Cashflow
Sep 266.12
Sep 266.11
Sep 266.2
Aug 266.58
Aug 266.31
Aug 266.68
Aug 266.61
Jul 266.57
Jul 266.95
Jul 266.87
Jul 266.16
Jul 266.44
Jun 2611.84
Jun 2612.01
Jun 2613.18
Jun 2612.75
May 2613.57
May 2615.18
May 2615.37
May 2616.54
Apr 2617.31
Apr 2615.94
Apr 2616.42
Apr 2615.49
Apr 2615.08
Mar 262662.79
Mar 262617.42
Mar 262662.79
Mar 262589.5
Feb 262739.56
Feb 262851.24
Feb 262851.24
Feb 262928.02
Jan 262938.49
Jan 262945.47
Jan 262823.32
Jan 262952.45
Jan 263071.1
Jun 2532.41
Jun 2533.24
Jun 2533.05
Jun 2533.59
May 2532.56
May 2532.1
May 2529.97
May 2530.39
May 2530.88
Apr 2530.81
Apr 2530.88
Apr 2530.43
Apr 2529.93
Mar 2521.67
Mar 2522.16
Mar 2522.62
Mar 2523
Feb 2523.73
Feb 2523.95
Feb 2523.35
Feb 2523.62
Jan 2523.35
Jan 2523.81
Jan 2524.49
Jan 2524.52
Jan 2523.54
Dec 2426.09
Dec 2427.15
Dec 2427.93
Dec 2428.79
Nov 2429.79
Nov 2430.24
Nov 2429.95
Nov 2431.63
Nov 2430.31
Oct 2429.83
Oct 2431.63
Oct 2430.86
Oct 2431.66
Sep 2414.52
Sep 2414.39
Sep 2413.91
Sep 2413.49
Aug 2414.87
Aug 2415.65
Aug 2417.21
Aug 2416.14
Aug 2415.36
Jul 2415.56
Jul 2415.39
Jul 2415.3
Jul 2415.21
Jun 2417.3
Jun 2417.27
Jun 2417.63
Jun 2417.6
May 2417.47
May 2418.13
May 2418.36
May 2417.86
May 2417.83
Apr 2417.3
Price to Book
0.20.30.40.50.60.7med 0.32Dec 24Apr 25Jul 25Nov 25Feb 26Jun 26Sep 26
004720.KS Price to Book by year
PeriodPrice to Book
Sep 260.44
Sep 260.44
Sep 260.45
Aug 260.47
Aug 260.46
Aug 260.48
Aug 260.48
Jul 260.47
Jul 260.5
Jul 260.5
Jul 260.44
Jul 260.46
Jun 260.43
Jun 260.44
Jun 260.48
Jun 260.46
May 260.49
May 260.55
May 260.56
May 260.6
Apr 260.63
Apr 260.58
Apr 260.6
Apr 260.56
Apr 260.55
Mar 260.28
Mar 260.27
Mar 260.28
Mar 260.27
Feb 260.29
Feb 260.3
Feb 260.3
Feb 260.31
Jan 260.31
Jan 260.31
Jan 260.3
Jan 260.31
Jan 260.32
Dec 250.31
Dec 250.31
Dec 250.31
Dec 250.31
Nov 250.3
Nov 250.29
Nov 250.3
Nov 250.3
Oct 250.3
Oct 250.3
Oct 250.3
Oct 250.31
Oct 250.32
Sep 250.32
Sep 250.33
Sep 250.33
Sep 250.32
Aug 250.32
Aug 250.32
Aug 250.33
Aug 250.33
Aug 250.33
Jul 250.31
Jul 250.32
Jul 250.32
Jul 250.31
Jun 250.31
Jun 250.32
Jun 250.32
Jun 250.32
May 250.31
May 250.31
May 250.29
May 250.29
May 250.3
Apr 250.29
Apr 250.3
Apr 250.29
Apr 250.29
Mar 250.31
Mar 250.32
Mar 250.33
Mar 250.33
Feb 250.34
Feb 250.35
Feb 250.34
Feb 250.34
Jan 250.34
Jan 250.35
Jan 250.36
Jan 250.36
Jan 250.34
Dec 240.31
Dec 240.32
Dec 240.33
Dec 240.34
Nov 240.35
Nov 240.35
Nov 240.35
Nov 240.37
Nov 240.36
Oct 240.35
PharmGen Science, Inc.
004720.KS
Stockpicker

Video analysis: 004720.KS

All videos

No video analysis for this stock yet. Request one from our team.

Your email is used only to follow up on this request. We do not add you to marketing lists. Privacy Policy

Similar companies

Disclaimer: The historical data presented on this platform is provided by Financial Modeling Prep. Stock Picker is a platform for informational purposes only and does not provide financial advice. Users are encouraged to conduct their own research and consult with a qualified financial advisor before making investment decisions.